Virtu Financial’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-17,230
| Closed | -$1.99M | – | 1870 |
|
|
2024
Q3 | $1.99M | Buy |
+17,230
| New | +$1.99M | 0.11% | 143 |
|
|
2024
Q2 | – | Sell |
-4,212
| Closed | -$581K | – | 1689 |
|
|
2024
Q1 | $581K | Buy |
+4,212
| New | +$581K | 0.04% | 380 |
|
|
2023
Q3 | – | Sell |
-5,353
| Closed | -$505K | – | 1671 |
|
|
2023
Q2 | $505K | Buy |
+5,353
| New | +$505K | 0.04% | 397 |
|
|
2021
Q3 | – | Sell |
-6,410
| Closed | -$624K | – | 1799 |
|
|
2021
Q2 | $624K | Buy |
6,410
+1,895
| +42% | +$184K | 0.06% | 379 |
|
|
2021
Q1 | $439K | Sell |
4,515
-1,527
| -25% | -$148K | 0.03% | 586 |
|
|
2020
Q4 | $579K | Sell |
6,042
-13,877
| -70% | -$1.33M | 0.06% | 395 |
|
|
2020
Q3 | $1.92M | Buy |
19,919
+13,655
| +218% | +$1.31M | 0.33% | 48 |
|
|
2020
Q2 | $764K | Buy |
+6,264
| New | +$764K | 0.09% | 252 |
|
|
2019
Q4 | – | Sell |
-4,695
| Closed | -$423K | – | 1703 |
|
|
2019
Q3 | $423K | Buy |
+4,695
| New | +$423K | 0.03% | 581 |
|
|
2019
Q2 | – | Sell |
-9,211
| Closed | -$812K | – | 1696 |
|
|
2019
Q1 | $812K | Buy |
+9,211
| New | +$812K | 0.05% | 365 |
|
|
2018
Q4 | – | Sell |
-4,114
| Closed | -$506K | – | 1832 |
|
|
2018
Q3 | $506K | Sell |
4,114
-3,177
| -44% | -$391K | 0.03% | 594 |
|
|
2018
Q2 | $716K | Sell |
7,291
-8,450
| -54% | -$830K | 0.04% | 588 |
|
|
2018
Q1 | $1.31M | Buy |
+15,741
| New | +$1.31M | 0.07% | 275 |
|